Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rapid Dose Therapeutics Corp., a diversified health and wellness company, has reported a significant revenue increase of 42% for the fiscal year 2024, although operating expenses and net comprehensive loss saw slight increases. The company has expanded its product range and developed strategic partnerships, notably entering the pharmaceutical space with an oral anesthesia for dental use and launching erectile dysfunction products.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.